Form 4 for BMY Bristol Myers Squibb
Accepted 2024-11-05 00:00:00 ET · period of report 2024-11-01 · accession 0000014272-24-000149 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-05 | 2024-11-01 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | P - Purchase | $54.68 | +1,830 | 62.1K | +3% | +$100.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2024-11-01 | P | A | 1,830 | $54.68 | 62,109 | D | — | — |